Private equity giant Advent International is purchasing a controlling stake in India's Suven Pharmaceuticals, a Hyderabad-based contract research and manufacturing services company, for $762 million.

Advent has agreed to buy 50.1% of Suven from India's Jasti family, a deal that will trigger a mandatory offer by Advent to Suven's minority shareholders for another 26% stake.